Marcellusi A, Bini C, Corinti S, Fioravanti L, Dalla Vedova L, Amorosi SL, et al. [Cost-Effectiveness Analysis of Maribavir in Patients with Post-Transplant Cytomegalovirus Infection or Disease that are Refractory or Resistant to Conventional Therapy]. FE [Internet]. 2023 Dec. 7 [cited 2025 Jul. 23];24(1). Available from: https://provafe.seedstm.com/index.php/FE/article/view/1548